UBS/CALL/DOCMORRIS/90.005/0.02/20.12.24 Stock

UBS/CALL/DOCMORRIS/90.005/0.02/20.12.24 Share Price

DOCBFU

CH1315872700

Market Closed - Swiss Exchange 16:20:00 17/05/2024 BST
0.15 ^CHF	-11.76%

Current month	-46.43%
1 month	-64.29%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart DOCMORRIS AG

Chart UBS/CALL/DOCMORRIS/90.005/0.02/20.12.24

Latest news about DOCMORRIS AG

DOCMORRIS : Sell rating from UBS	05-16	ZD
DocMorris AG: DocMorris announces results of Tender Offer	05-14	EQ
DocMorris AG: Daniel Wüest becomes new CFO at DocMorris	05-08	EQ
DocMorris announces the start of the tender offer period for its Outstanding Convertible Bonds due 2025	05-06	EQ

More news

Quotes 5-day view

Date	Price	Change
17/05/24	0.15	-11.76%
14/05/24	0.17	-5.56%
13/05/24	0.18	-5.26%
10/05/24	0.19	-5.00%

Delayed Quote Swiss Exchange

Last update May 17, 2024 at 04:20 pm

More quotes

Static data

Product type	Warrants
Buy / Sell	CALL
Underlying	DOCMORRIS AG
Issuer	UBS
	DOCBFU
ISIN	CH1315872700
Date issued	10/01/2024
Strike	90 CHF
Maturity	20/12/2024 (217 Days)
Parity	50 : 1
Emission price	0.36 CHF
Emission volume	N/A
Settlement	physique
Currency	CHF

Technical Indicators

Highest since issue	0.56 CHF
Lowest since issue	0.15 CHF
Delta	0.39x
Omega	3.882
Premium	38.58x
Gearing	10x
Moneyness	0.7777
Difference Strike	20 CHF
Difference Strike %	+22.23%
Spread	0.02 CHF
Spread %	13.33%
Theoretical value	0.1400
Implied Volatility	60.57 %
Total Loss Probability	77.37 %
Intrinsic value	0.000000
Present value	0.1400
Break even	97.01 CHF
Theta	-0x
Vega	0x
Rho	0x

Company Profile

Zur Rose Group AG is a Switzerland-based company engaged in the drug distribution sector. The Company focuses on the wholesale trade of medicines, as well as operation of a mail-order pharmacy. The Company's activities are divided into two business segments: Zur Rose and DocMorris. The Zur Rose division includes wholesale business and provides drugs to medical doctors, health insurance companies, hospitals and healthcare companies, among others. The DocMorris division manages the mail-order business for drug retail. The Company operates in Switzerland, Germany and the Netherlands through a number of subsidiaries, such as Zur Rose Suisse AG, Zur Rose Pharma GmbH, BlueCare AG, DocMorris NV, Eurapon Pharmahandel GmbH and Vitalsana BV.

Sector

More about the company

Ratings for DocMorris AG

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Consensus: DocMorris AG

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

70 CHF

Average target price

99.24 CHF

Spread / Average Target

+41.77%

Consensus